As the complexity of patient care increases, so does the prevalence of polypharmacy, defined as the concurrent use of multiple medications by a patient. This phenomenon, while sometimes necessary, poses significant challenges due to potential drug-drug interactions (DDIs).
With the aging population and the rise in chronic diseases, polypharmacy has become commonplace. It is particularly prevalent among the elderly, where it is associated with increased morbidity and mortality, decreased physical and cognitive functioning, and a higher risk of hospitalization.
DDIs occur when the effect of one drug is altered by another. They can lead to decreased therapeutic efficacy or increased toxicity. The risk of DDIs exponentially increases with each additional medication, making polypharmacy a significant concern.
Healthcare professionals can employ several strategies to manage polypharmacy effectively. Regular medication reviews are crucial, focusing on the appropriateness of each drug. Deprescribing, the systematic process of identifying and discontinuing drugs in instances where existing or potential harms outweigh benefits, is also an important tool.
Modern healthcare technology can assist in managing polypharmacy. Electronic health records (EHRs) and clinical decision support systems (CDSS) can flag potential DDIs, aiding clinicians in prescribing decisions. However, these tools' effectiveness depends on their correct and consistent use.
Navigating the complex landscape of polypharmacy and DDIs is a crucial aspect of modern healthcare. Through proactive strategies like regular medication reviews and deprescribing, along with the effective use of technology, healthcare professionals can mitigate the risks associated with polypharmacy, enhancing patient safety and outcomes.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation